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Vitamin D deficiency is prevalent in human populations and has been linked to
immune dysfunction. Here we explored the effects of cholecalciferol supplementation
on circulating cytokines in severely vitamin D deficient [blood 25(OH)D << 30 nmol/L]
adolescents aged 12–15 from Mongolia. The study included 28 children receiving
800 IU daily cholecalciferol for 6 months spanning winter and spring, and 30 children
receiving placebo during the same period. The levels of 25(OH)D were assessed at
baseline, 3 and 6 months. Twenty-one cytokines were measured in serum at baseline
and at 6 months. Changes in 25(OH)D and cytokines were assessed using paired
parametric tests. The median blood 25(OH)D concentration at baseline was 13.7 nmol/L
(IQR = 10.0–21.7). Supplementation tripled blood 25(OH)D levels (p < 0.001) and was
associated with elevated interleukin (IL)-6 (p = 0.043). The placebo group had reduced
macrophage inflammatory protein (MIP)-1α (p= 0.007) and IL-8 (p= 0.034) at 6 months.
Although limited by a small sample size, these findings suggest that cholecalciferol
supplementation and seasonality may impact systemic immunity in adolescents,
identifying chemokines as potentially important biomarkers of vitamin D status in this
Northeast Asian population. Larger clinical trials are warranted to validate these results.
Clinical Trial Registration: www.ClinicalTrial.org, Identifier: NCT01244204.
Keywords: vitamin D deficiency, cholecalciferol supplementation, cytokines, chemokines, Mongolia, Northeast
Asia, adolescents
INTRODUCTION
Accumulating evidence indicates that vitamin D has important non-skeletal functions, particularly
in the immune system (1–5). Thus, vitamin D deficiency has been associated with increased risk
for diseases tightly linked to immune function, such as autoimmune conditions and respiratory
tract infections (1, 4–6). Notably, a recent meta-analysis found that vitamin D supplementation
significantly reduced the risk of acute respiratory infections most prominently in individuals
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with low serum 25(OH)D concentrations (<25 nmol/L) (7). In
addition, our earlier studies in Mongolian children, in whom
vitamin D deficiency [25(OH)D <25 nmol/L or 10 ng/ml (8)]
prevalence exceeds 80%, indicated a significant reduction of
acute respiratory tract infection associated with cholecalciferol
supplementation (9, 10). Similar observations were made
regarding the relationship of vitamin D and immunity to TB
infection in other cohorts (2).
The in vivo effects of vitamin D on immunity are still
incompletely understood in the setting of different human
populations and genetic backgrounds (3), although studies
performed in vitro and in animal models indicate that the nature
of vitamin D effects on immunity is context- and cell type-
dependent. For example, vitamin D exerts stimulatory effects
on monocytes and macrophages inducing interleukin (IL)-1
production, while modulating adaptive immune responses by
increasing IL-10 production by dendritic and T cells (1, 5)
and these effects are differentially regulated in the presence of
pathogen stimuli (11).
Given the protective effects of vitamin D against respiratory
infections and the evidence of the vitamin’s immune roles in vitro,
here we tested the hypothesis that 6 months of cholecalciferol
supplementation in severely vitamin D-deficient adolescents
would result in a significant change in the circulating mediators
of antiviral and antibacterial immunity.
METHODS
Study Setting and Participant Recruitment
This study is part of a feasibility pilot trial (completed in
2010) to assess the effects of vitamin D supplementation on
latent TB incidence in 120 Mongolian children (ClinicalTrial.org
ID: NCT01244204) (9). The screening and recruitment of
participants was described previously (9, 12). Briefly, children
aged 12–15 years residing inUlaanbaatar, the capital ofMongolia,
were recruited. The study intervention consisted of 800 IU
vitamin D or placebo (Tishcon Corp., Salisbury, MD) daily for
6 months from November 2009 to May 2010, during the coldest
period of the Mongolian year. The choice of the vitamin D
supplementation regimen was guided by the National Academy
of Medicine (formerly the Institute of Medicine) (13) and
the Endocrine Society (14) guidelines, according to which the
recommended dietary allowance for vitamin D in adolescents
ranges from 600 to 1000 IU/day.
For the current analysis, 58 paired serum samples (baseline
and 6 months) were randomly selected from the parent placebo
(n = 30/59) and supplemented (n = 28/61) groups. This
study was designed to supply pilot data for future larger
studies in the same cohort, therefore no formal sample size
calculations were performed, and sample size was determined
based on the available study budget. All research procedures were
approved by the institutional review boards of the Mongolian
Ministry of Health, National University of Mongolia and
the Harvard School of Public Health (Ref. #16571). Written
consent to participate was collected from both children and
their parents.
Sample Collection and Diagnostic Testing
Blood (8.0ml) was collected by venipuncture into red top
tubes (Becton Dickinson). Serum was isolated by centrifugation
and stored at −80◦C prior to analysis. Measurement of
25(OH)D was performed using LIAISON 25-OH Vitamin
D TOTAL assay [DiaSorin S.p.A. (Italy)] at 0, 3, and 6
months. The concentrations of 21 cytokines representing
chemokines (macrophage inflammatory protein (MIP)-1α, MIP-
1β, MIP-3α, interleukin (IL)-8, fractalkine, interferon-inducible
T-cell alpha chemoattractant (ITAC), homeostatic (IL-2, IL-7,
granulocyte-macrophage colony-stimulating factor (GM-CSF),
classic proinflammatory (IL-1β, IL-6, tumor necrosis factor
(TNF), Th17-type proinflammatory (IL-17α, IL-23), regulatory
(IL-10, IL-21) as well as Type I [interferon (IFN)γ, IL-12] and
Type II cytokines (IL-13, IL-4, IL-5) (see Supplementary Table 1
for details on the cytokines and assay sensitivity) were measured
at baseline and at 6 months using the Human High Sensitivity
T Cell Panel (HSTCMAG-28SK) on a MAGPIX instrument
(EMD Millipore). All experimental assays were performed
by research personnel blinded to the supplementation status
of participants.
Statistical Analysis
Differences in demographic characteristics between the
cholecalciferol supplemented and placebo groups were assessed
using Independent-Samples Mann-Whitney U and Chi-
Square Tests. Mean height-for-age and height-for-BMI z
scores were calculated using WHO Anthro software (15).
Cytokine concentrations were log10-transformed prior to
analysis to facilitate visualization, while hypothesis testing
was performed on the original (untransformed) data. To
enhance the power of analysis, serum 25(OH)D and cytokine
concentrations across study visits were compared using paired
t-test. Differences between the placebo and cholecalciferol
supplemented groups at each time point were assessed by one
sample t-test. To compare the cumulative direction change in
cytokine concentrations between the supplemented and placebo
groups, we first calculated the proportion of cytokines that
were found on average increased or decreased at follow-up
for each participant group (solid dots for each cytokine in
Figure 2), and then performed a Chi-Square test of the null
hypothesis that there was no significant change in cumulative
cytokine concentrations between the placebo and cholecalciferol-
supplemented children. All statistical analyses and graphing were
performed using IBM SPSS V.23 (NY, US) and GraphPad Prism
V.6.0. (CA, US).
RESULTS
Participant Demographics
Samples from a total of 58 children were analyzed. At
baseline the median serum 25(OH)D concentration was 13.7
nmol/L and basic socio-demographic characteristics were not
significantly different between the supplemented and placebo
groups (Supplementary Table 2).
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FIGURE 1 | Longitudinal changes in blood 25(OH)D concentrations in Mongolian children. Measurements were performed in vitamin D3 supplemented (n = 25) and
placebo (n = 30) groups. Circles and bars denote means and 95% confidence intervals, respectively. Intraindividual changes within each group and inter-group
differences were assessed by paired t-test and one-sample t test (p < 0.05), respectively. *p-values <0.001, NS, not significant.
FIGURE 2 | Longitudinal changes in blood cytokine concentrations in Mongolian children. Measurements were performed on serum samples from vitamin D
supplemented (n = 25) and placebo (n = 27) groups. Circles represent means of difference between log-transformed cytokine concentrations at the 6 month
follow-up visit and baseline. Bars are 95% confidence intervals. Cytokine change is considered significant when its respective confidence intervals are found entirely
on the positive or negative sides of the x-axis and are not spanning the “0” reference line. Stars denote the cytokines (MIP-1α, IL-8, IL-6) exhibiting statistically
significant changes (p < 0.05) see Supplementary Figure 1 for participant-level data for these cytokines.
Changes in Systemic 25(OH)D
Concentrations
First, we examined blood 25(OH)D levels at baseline (November)
and 3 and 6 months (February and May, respectively) (Figure 1).
Children receiving placebo had significantly reduced 25(OH)D
in February (mean = 10.6 nmol/L, mean fold change (MFC) =
1.4, p < 0.001) and an increase of 25(OH)D in May (mean =
23.2 nmol/L, MFC = 1.5, p < 0.001) compared to November.
On the other hand, children receiving cholecalciferol exhibited
an elevation of 25(OH)D in February (mean= 44.3 nmol/L,MFC
= 3.1, p < 0.001) and this increase was sustained in May (mean
= 49.0 nmol/L, MFC = 3.5, p < 0.001) compared to November.
Compared to the placebo group, cholecalciferol supplemented
participants had significantly higher blood 25(OH)D levels in
both February (4.2-fold, p< 0.001) andMay (2.1-fold, p< 0.001)
(Figure 1).
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Changes in Systemic Cytokine
Concentrations
Due to missing data, paired cytokine analysis was performed
for 52 out of 58 (27 placebo and 25 supplemented) participants.
The mean cytokine concentrations in the placebo and
supplemented groups at baseline and 6 months are listed
in Supplementary Table 3; a cross-sectional analysis did
not detect any significant differences (at p ≤ 0.05) in the
cytokine concentrations between the placebo and supplemented
groups at baseline or at 6 months. Therefore, we compared
intra-participant changes in cytokine concentrations between
baseline and 6 months after study initiation (Figure 2). In
the supplemented group, 85.7% (18/21) and 14.3% (3/21) of
measured cytokines exhibited a positive and negative change,
respectively, while in the placebo group the mean difference
in cytokine concentrations was negative for 76.2% (16/21)
and positive for 23.8% (5/21) of the assessed cytokines. Thus,
cholecalciferol supplementation had a significant effect on the
cumulative direction of change in blood cytokine concentrations
compared to placebo (Chi-square statistic = 16.2, p < 0.001).
The cholecalciferol supplemented group had elevated IL-6 (MFC
= 1.4, p = 0.043) (Figure 2 and Supplementary Figure 1), while
the levels of chemokines MIP-1α and IL-8 were significantly
reduced in the placebo group (MFC = 2.38, p = 0.007 and MFC
= 1.31, p = 0.034 for MIP-1α and IL-8, respectively, Figure 2
and Supplementary Figure 1).
DISCUSSION
Here we longitudinally examined the effect of vitamin D
supplementation on the circulating cytokines representing
several different immune pathways. We conducted the study in
Mongolia, where extreme vitaminD deficiency is common (9, 12)
and vitamin D supplementation results in a substantial increase
of circulating 25(OH)D levels (9, 12, 16). Here the supplemented
group’s 25(OH)D levels increased gradually from 13.7 to
49.0 nmol/L, while the un-supplemented adolescents remained
severely deficient with blood 25(OH)D levels remaining <25
nmol/L throughout the study. Interestingly, in May the placebo
group had higher 25(OH)D concentrations compared to
November likely due to higher sun exposure in Spring, although
these levels were still under the “critical” threshold (7) of
25 nmol/L (Figure 1).
Our findings should be interpreted in the light of several
limitations. First, the study was designed as a pilot with a small
sample size, which reduced the power to detect small differences
in blood cytokine concentrations due to high inter-individual
variability (see Supplementary Table 3). However, we addressed
this limitation by performing a paired statistical analysis and
compared changes in cytokine concentrations intra-individually,
allowing us to reduce the effects of inter-individual variability.
The small sample size also limited our choices for data analysis,
and we were unable to employ multivariable modeling in this
study. The cytokine panel size, time points covered by the
study and a rather conservative vitamin D regimen are other
important limitations of this work. Nevertheless, this study
provides novel hypothesis-generating insights at the impact of
vitamin D supplementation on the immunology of severely
vitamin D deficient Mongolian adolescents, as discussed below.
The effects of vitamin D supplementation on human
immunology have now been assessed by several studies; including
large scale randomized controlled trials and rigorous meta-
analyses, which reported a lack of any effect of vitamin D
supplementation on systemic biomarkers, such as IL-6 or C-
reactive protein (17–19). Notably, most of these studies describe
data from Western countries and there is a paucity of similar
research from lower resource settings, such as Mongolia. To the
best of our knowledge, our study is the first to report on the
effects of supplementing vitamin D on systemic immunology in
a Mongolian cohort, one distinguishing feature of which is the
severity of vitamin D deficiency, where the mean baseline/pre-
supplementation level of circulating vitamin D is 13.7 nmol/L
and hence a few-fold lower compared to that seen in many
other studies from Western countries (17, 18). This is important
since a recent meta-analysis indicates that 25 nmol/L is a critical
threshold of vitaminD deficiency associated with elevated risk for
acute respiratory infection (7) and other studies demonstrate that
vitamin D supplementation alters circulating IFN-g and IL-10
levels in individuals with vitamin D insufficiency (20), suggesting
that vitamin D supplementation exerts most effect on human
immunity in the context of severe vitamin D deficiency.
Compared to baseline, 6 months of cholecalciferol
supplementation resulted in a cumulative shift toward elevation
for a majority (∼86%) of measured cytokines. This was in
stark contrast with the effect seen in the placebo group,
where compared to baseline ∼76% of cytokines exhibited a
cumulative shift toward reduction, suggesting that vitamin D
deficiency could contribute to a gradual change of immune
variables over winter. Further, the vitamin D-deficient children
had significantly reduced MIP-1α (CCL3) and IL-8 (CXCL8)
concentrations at 6 months compared to baseline. This effect
was not seen in the supplemented participants, suggesting
that vitamin D deficiency is implicated in the reduction of
these chemokines playing roles in leukocyte homing and
activation and mediating antibacterial and antiviral immune
responses (21, 22). Previously, vitamin D supplementation
in the context of chronic kidney disease was implicated
in decreasing the concentrations of another chemokine,
monocyte chemoattractant protein-1, and our findings provide
further evidence for the role of vitamin D in chemokine
homeostasis (23).
The increased IL-6 observed in the supplemented children
is consistent with IL-6 up-regulation in the peripheral blood
mononuclear cells of vitamin D supplemented multiple sclerosis
patients (24). At the same time vitamin D deficiency was
associated with high IL-6 (25) and vitamin D supplementation
down-regulated IL-6 in some studies (26–29). These seemingly
contradictory findings regarding IL-6 and vitamin D could
be attributed to various confounders and differences among
the studies, such as the duration and dosage of vitamin
D supplementation, the participants’ genetic background,
underlying clinical conditions, effects of clinical therapy, and
extent of vitamin D insufficiency/deficiency at baseline.
Our findings are consistent with other studies reporting
an increase of IL-10 in vitamin D supplemented individuals
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(20, 30, 31), as we also observed a strong trend to elevated
IL-10 in the supplemented children. Somewhat surprisingly,
we saw no change in IFN-γ in our study, the Type
I cytokine that was significantly elevated in vitamin D-
supplemented US and Mexican adults (20, 30), which could
reflect the diverse effects of vitamin D in different age and/or
ethnic groups.
An important factor to consider when interpreting our
results in the light of earlier research is participant age, which
has important implications for the assessment of immune
responses (32). A recent study by Berlanga-Taylor et al. (19), for
example, reported a lack of any effect of 1 year-long vitamin
D supplementation on circulating IFN-γ, IL-10, IL-8, IL-6, or
TNF. However, the mean age of participants in this study was 72
years and their mean pre-supplementation vitamin D level was
50.0 nmol/L, thus precluding a direct comparison of this study’s
outcomes with our results.
In summary, this study for the first time assessed the
immune effects of cholecalciferol supplementation in severely
vitamin D deficient adolescents from Northeast Asia. Although
it is challenging to differentiate between the effects of
vitamin D supplementation versus seasonality, cholecalciferol
supplementation appeared to influence systemic immune
mediators in this population. The small sample size precludes
making strong conclusions based on the study findings. A
larger clinical trial is warranted to validate these results and
explore in detail the utility of the identified cytokines as
biomarkers of vitamin D-mediated immune (dys-) function as
well as the associations of the relevant immune pathways with
clinical outcomes.
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